Correlation Between Liquidia Technologies and Legend Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Liquidia Technologies and Legend Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Liquidia Technologies and Legend Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Liquidia Technologies and Legend Biotech Corp, you can compare the effects of market volatilities on Liquidia Technologies and Legend Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Liquidia Technologies with a short position of Legend Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Liquidia Technologies and Legend Biotech.

Diversification Opportunities for Liquidia Technologies and Legend Biotech

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Liquidia and Legend is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Liquidia Technologies and Legend Biotech Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Legend Biotech Corp and Liquidia Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Liquidia Technologies are associated (or correlated) with Legend Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Legend Biotech Corp has no effect on the direction of Liquidia Technologies i.e., Liquidia Technologies and Legend Biotech go up and down completely randomly.

Pair Corralation between Liquidia Technologies and Legend Biotech

Given the investment horizon of 90 days Liquidia Technologies is expected to generate 0.85 times more return on investment than Legend Biotech. However, Liquidia Technologies is 1.18 times less risky than Legend Biotech. It trades about 0.18 of its potential returns per unit of risk. Legend Biotech Corp is currently generating about 0.06 per unit of risk. If you would invest  1,151  in Liquidia Technologies on December 29, 2024 and sell it today you would earn a total of  358.00  from holding Liquidia Technologies or generate 31.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Liquidia Technologies  vs.  Legend Biotech Corp

 Performance 
       Timeline  
Liquidia Technologies 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Liquidia Technologies are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Liquidia Technologies sustained solid returns over the last few months and may actually be approaching a breakup point.
Legend Biotech Corp 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Legend Biotech Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Legend Biotech may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Liquidia Technologies and Legend Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Liquidia Technologies and Legend Biotech

The main advantage of trading using opposite Liquidia Technologies and Legend Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Liquidia Technologies position performs unexpectedly, Legend Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will offset losses from the drop in Legend Biotech's long position.
The idea behind Liquidia Technologies and Legend Biotech Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance